|
|
|
|
|
|
This month's newsletter focuses on how AI, digital manufacturing, predictive modeling, and scalable bioprocessing are accelerating the development and commercialization of next-generation biologics and advanced therapies.
|
|
|
|
|
Explore how AI, smart manufacturing, real-time process monitoring, and strategic collaboration are enabling the transition to adaptive biomanufacturing. Learn how digital transformation is improving efficiency, flexibility, and speed while keeping scientific expertise at the center of decision-making.
|
|
|
|
|
Discover how predictive modeling and machine learning are transforming media development by reducing experimental burden, accelerating optimization, and helping developers identify promising formulations faster while maintaining product quality.
|
|
|
|
|
Hear directly from Thermo Fisher Scientific experts as they discuss how proactive raw material management, process analytical technologies (PAT), and AI-driven predictive modeling work together to improve consistency, reduce development timelines, and enable more informed manufacturing decisions.
|
|
|
|
|
Learn how upstream bioprocessing is becoming a defining factor in ADC development. This article explores how predictive modeling, scalable media strategies, and data-driven process development help improve conjugation readiness, manufacturing robustness, and commercialization success.
|
|
|
|
|
Explore how adaptable clinical development, scalable manufacturing, resilient supply chains, and proactive regulatory planning can strengthen submissions, reduce risk, and accelerate access to innovative therapies.
|
|
|
|
|
Learn how automation, closed manufacturing systems, scalable bioreactors, and digital integration are helping developers industrialize cell therapy manufacturing while improving reproducibility, efficiency, and patient access.
|
|
|
